ALLMedicine™ Urine Calcium Center

Sep 29th, 2021 - Technetium-99 m sestamibi parathyroid scintigraphy (MIBI scan) has been used to localize abnormal glands in patients with primary hyperparathyroidism to guide parathyroidectomy. This series aimed to identify the biochemical and histopathological c...

Jul 31st, 2021 - Primary hyperparathyroidism and familial hypocalciuric hypercalcemia have similar biochemical profiles, and calcium-to-creatinine-clearance ratio helps distinguish the two. Additionally, 24-hour urine calcium >400 mg/day indicates surgery and guid...

Jul 27th, 2021 - Recent experimental studies have shown that a non-calcium based phosphate binder sevelamer hydrochloride can increase intestinal calcium absorption in contrast to lanthanum carbonate. It is unknown whether such the difference may have an effect on...

Jul 22nd, 2021 - In vitro experiments demonstrate calcium oxalate (CaOx) supersaturation (SS) drives CaOx nucleation and growth. We investigated the link between 24-hour urine SS CaOx and in vivo stone growth through a natural history, imaging study. Using an inst...

Jun 8th, 2021 - To prospectively examine the occurrence of hypercalciuria and changes in bone metabolite markers in pediatric patients during immobilization. In total, 13 children with an orthopedic disease requiring immobilization longer than 2 weeks were enroll...

Jul 27th, 2021 - Recent experimental studies have shown that a non-calcium based phosphate binder sevelamer hydrochloride can increase intestinal calcium absorption in contrast to lanthanum carbonate. It is unknown whether such the difference may have an effect on...

Feb 2nd, 2021 - There are multiple disorders (each with a unique underlying cause) that result in unusually high circulating levels of FGF23, which in turn result in renal phosphate wasting and reduced (or aberrantly normal in relationship to elevated FGF23) leve...

Jul 26th, 2018 - Hypoparathyroidism is a rare disorder in which parathyroid hormone (PTH) is markedly decreased or absent from the circulation. It is the only remaining hormone deficiency state for which replacement with the missing hormone has been heretofore una...

Sep 28th, 2017 - The purpose of this pilot, 12 week, clinical research study is to determine if supplementation with Vitamin D will improve the clinical outcome in subjects with chronic urticaria and angioedema (CUA). Vitamin D is a key element in the regulation o...

May 4th, 2017 - The project proposed is a randomised controlled multicentre study of infants with epilepsy who have failed to respond to two or more pharmacological treatments (antiepileptic drugs (AEDs) or corticosteroids), comparing ketogenic diet to treatment ...

Sep 15th, 2021 - NEW YORK (Reuters Health) - In adults with chronic hypoparathyroidism, an investigational prodrug of parathyroid hormone, TransCon PTH, allowed most participants in a small randomized trial to reduce or forgo conventional therapy of vitamin D and ...

Mar 9th, 2021 - Almost 1 in 4 men and women diagnosed with kidney stones have osteoporosis or a history of fracture at the time of their diagnosis, yet fewer than 10% undergo bone mineral density (BMD) screening, a retrospective analysis of a Veterans Health Admi...

Dec 5th, 2020 - Weekly high-dose vitamin D supplementation improves joint and muscle pain related to anastrozole therapy in breast cancer patients with low vitamin D levels, according to the results of a phase II study. Musculoskeletal symptoms are a known advers...

Dec 24th, 2019 - NEW YORK (Reuters Health) - Vitamin D supplementation in doses up to 10,000 IU/day appears to be safe and well tolerated, though higher doses increase the risk of hypercalciuria and mild hypercalcemia, according to a secondary analysis from the Ca...

Apr 4th, 2019 - NEW ORLEANS — Recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) (Natpara, Shire) was safe and effective over 6 years of continuous use for the treatment of adults with chronic hypoparathyroidism, new research shows. Findings from the long-t...